EXECUTIVE ENGAGEMENTS
POOL
INTERACTIONS
PARTICIPANTS
VALIDATIONS
COMPANIES
* Login for a full stack data experience
DATE
JAN 2022
TABLES
22
PAGES
94
EDITION
8
PRICE
USD 5600
CODE
MCP22960
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
What's New for 2022?
» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year
SELECT PLAYERS
3M; Acrux Limited; Bayer AG; Biofarmitalia s.r.l; Cipla Inc.; Crescita Therapeutics Inc.; Galderma S.A.; GlaxoSmithKline plc; Janssen Global Services, LLC; Lohmann Therapie-Systeme AG; Medpharm; Mylan N.V.; Nitto Denko Corporation; Novartis AG; Pharmatek Laboratories, Inc.; Pocono Coated Products LLC; Skinvisible Pharmaceuticals, Inc.; Stiefel Laboratories, Inc.; Tapemark; Valeant Pharmaceuticals International, Inc.; West Pharmaceutical Services, Inc.
SEGMENTS
» Product (Semi-Solid Formulations, Liquid Formulations, Solid Formulations, Transdermal Products) » Route of Administration (Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, Vaginal Drug Delivery) » End-Use (Home Care Settings, Hospitals & Clinics, Burn Centers, Other End-Uses)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
I. METHODOLOGY |
II. EXECUTIVE SUMMARY |
1. MARKET OVERVIEW |
Influencer Market Insights |
World Market Trajectories |
Impact of Covid-19 and a Looming Global Recession |
Topical Drug Delivery – Global Key Competitors Percentage Market Share in 2022 (E) |
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) |
2. FOCUS ON SELECT PLAYERS |
3. MARKET TRENDS & DRIVERS |
4. GLOBAL MARKET PERSPECTIVE |
World Recent Past, Current & Future Analysis for Topical Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Topical Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Topical Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Semi-Solid Formulations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Semi-Solid Formulations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Semi-Solid Formulations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Liquid Formulations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Liquid Formulations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Liquid Formulations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Solid Formulations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Solid Formulations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Solid Formulations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Transdermal Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Transdermal Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Transdermal Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Home Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Burn Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Burn Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Burn Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Dermal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Dermal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Dermal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Nasal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Nasal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Nasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Ophthalmic Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Ophthalmic Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Ophthalmic Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Rectal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Rectal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Rectal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Vaginal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Vaginal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Vaginal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Topical Drug Delivery Market Analysis of Annual Sales in US$ Million for Years 2012 through 2027 |
III. MARKET ANALYSIS |
UNITED STATES |
Topical Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E) |
USA Recent Past, Current & Future Analysis for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
USA Historic Review for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
USA 15-Year Perspective for Topical Drug Delivery by Product - Percentage Breakdown of Value Sales for Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products for the Years 2012, 2021 & 2027 |
USA Recent Past, Current & Future Analysis for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
USA Historic Review for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
USA 15-Year Perspective for Topical Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
USA Recent Past, Current & Future Analysis for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
USA Historic Review for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
USA 15-Year Perspective for Topical Drug Delivery by Route Of Administration - Percentage Breakdown of Value Sales for Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery for the Years 2012, 2021 & 2027 |
CANADA |
Canada Recent Past, Current & Future Analysis for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Canada Historic Review for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Canada 15-Year Perspective for Topical Drug Delivery by Product - Percentage Breakdown of Value Sales for Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products for the Years 2012, 2021 & 2027 |
Canada Recent Past, Current & Future Analysis for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Canada Historic Review for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Canada 15-Year Perspective for Topical Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
Canada Recent Past, Current & Future Analysis for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Canada Historic Review for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Canada 15-Year Perspective for Topical Drug Delivery by Route Of Administration - Percentage Breakdown of Value Sales for Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery for the Years 2012, 2021 & 2027 |
JAPAN |
Topical Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E) |
Japan Recent Past, Current & Future Analysis for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Japan Historic Review for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Japan 15-Year Perspective for Topical Drug Delivery by Product - Percentage Breakdown of Value Sales for Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products for the Years 2012, 2021 & 2027 |
Japan Recent Past, Current & Future Analysis for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Japan Historic Review for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Japan 15-Year Perspective for Topical Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
Japan Recent Past, Current & Future Analysis for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Japan Historic Review for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Japan 15-Year Perspective for Topical Drug Delivery by Route Of Administration - Percentage Breakdown of Value Sales for Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery for the Years 2012, 2021 & 2027 |
CHINA |
Topical Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E) |
China Recent Past, Current & Future Analysis for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
China Historic Review for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
China 15-Year Perspective for Topical Drug Delivery by Product - Percentage Breakdown of Value Sales for Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products for the Years 2012, 2021 & 2027 |
China Recent Past, Current & Future Analysis for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
China Historic Review for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
China 15-Year Perspective for Topical Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
China Recent Past, Current & Future Analysis for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
China Historic Review for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
China 15-Year Perspective for Topical Drug Delivery by Route Of Administration - Percentage Breakdown of Value Sales for Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery for the Years 2012, 2021 & 2027 |
EUROPE |
Topical Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E) |
Europe Recent Past, Current & Future Analysis for Topical Drug Delivery by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
Europe Historic Review for Topical Drug Delivery by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Topical Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2021 & 2027 |
Europe Recent Past, Current & Future Analysis for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Europe Historic Review for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Topical Drug Delivery by Product - Percentage Breakdown of Value Sales for Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products for the Years 2012, 2021 & 2027 |
Europe Recent Past, Current & Future Analysis for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Europe Historic Review for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Topical Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
Europe Recent Past, Current & Future Analysis for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Europe Historic Review for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Topical Drug Delivery by Route Of Administration - Percentage Breakdown of Value Sales for Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery for the Years 2012, 2021 & 2027 |
FRANCE |
Topical Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E) |
France Recent Past, Current & Future Analysis for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
France Historic Review for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
France 15-Year Perspective for Topical Drug Delivery by Product - Percentage Breakdown of Value Sales for Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products for the Years 2012, 2021 & 2027 |
France Recent Past, Current & Future Analysis for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
France Historic Review for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
France 15-Year Perspective for Topical Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
France Recent Past, Current & Future Analysis for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
France Historic Review for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
France 15-Year Perspective for Topical Drug Delivery by Route Of Administration - Percentage Breakdown of Value Sales for Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery for the Years 2012, 2021 & 2027 |
GERMANY |
Topical Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E) |
Germany Recent Past, Current & Future Analysis for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Germany Historic Review for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Germany 15-Year Perspective for Topical Drug Delivery by Product - Percentage Breakdown of Value Sales for Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products for the Years 2012, 2021 & 2027 |
Germany Recent Past, Current & Future Analysis for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Germany Historic Review for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Germany 15-Year Perspective for Topical Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
Germany Recent Past, Current & Future Analysis for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Germany Historic Review for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Germany 15-Year Perspective for Topical Drug Delivery by Route Of Administration - Percentage Breakdown of Value Sales for Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery for the Years 2012, 2021 & 2027 |
ITALY |
Italy Recent Past, Current & Future Analysis for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Italy Historic Review for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Italy 15-Year Perspective for Topical Drug Delivery by Product - Percentage Breakdown of Value Sales for Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products for the Years 2012, 2021 & 2027 |
Italy Recent Past, Current & Future Analysis for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Italy Historic Review for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Italy 15-Year Perspective for Topical Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
Italy Recent Past, Current & Future Analysis for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Italy Historic Review for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Italy 15-Year Perspective for Topical Drug Delivery by Route Of Administration - Percentage Breakdown of Value Sales for Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery for the Years 2012, 2021 & 2027 |
UNITED KINGDOM |
Topical Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E) |
UK Recent Past, Current & Future Analysis for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
UK Historic Review for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
UK 15-Year Perspective for Topical Drug Delivery by Product - Percentage Breakdown of Value Sales for Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products for the Years 2012, 2021 & 2027 |
UK Recent Past, Current & Future Analysis for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
UK Historic Review for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
UK 15-Year Perspective for Topical Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
UK Recent Past, Current & Future Analysis for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
UK Historic Review for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
UK 15-Year Perspective for Topical Drug Delivery by Route Of Administration - Percentage Breakdown of Value Sales for Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery for the Years 2012, 2021 & 2027 |
REST OF EUROPE |
Rest of Europe Recent Past, Current & Future Analysis for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Europe Historic Review for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of Europe 15-Year Perspective for Topical Drug Delivery by Product - Percentage Breakdown of Value Sales for Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products for the Years 2012, 2021 & 2027 |
Rest of Europe Recent Past, Current & Future Analysis for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Europe Historic Review for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of Europe 15-Year Perspective for Topical Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
Rest of Europe Recent Past, Current & Future Analysis for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Europe Historic Review for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of Europe 15-Year Perspective for Topical Drug Delivery by Route Of Administration - Percentage Breakdown of Value Sales for Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery for the Years 2012, 2021 & 2027 |
ASIA-PACIFIC |
Topical Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E) |
Asia-Pacific Recent Past, Current & Future Analysis for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Topical Drug Delivery by Product - Percentage Breakdown of Value Sales for Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products for the Years 2012, 2021 & 2027 |
Asia-Pacific Recent Past, Current & Future Analysis for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Topical Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
Asia-Pacific Recent Past, Current & Future Analysis for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Topical Drug Delivery by Route Of Administration - Percentage Breakdown of Value Sales for Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery for the Years 2012, 2021 & 2027 |
REST OF WORLD |
Rest of World Recent Past, Current & Future Analysis for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of World Historic Review for Topical Drug Delivery by Product - Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of World 15-Year Perspective for Topical Drug Delivery by Product - Percentage Breakdown of Value Sales for Semi-Solid Formulations, Liquid Formulations, Solid Formulations and Transdermal Products for the Years 2012, 2021 & 2027 |
Rest of World Recent Past, Current & Future Analysis for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of World Historic Review for Topical Drug Delivery by End-Use - Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of World 15-Year Perspective for Topical Drug Delivery by End-Use - Percentage Breakdown of Value Sales for Home Care Settings, Hospitals & Clinics, Burn Centers and Other End-Uses for the Years 2012, 2021 & 2027 |
Rest of World Recent Past, Current & Future Analysis for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of World Historic Review for Topical Drug Delivery by Route Of Administration - Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of World 15-Year Perspective for Topical Drug Delivery by Route Of Administration - Percentage Breakdown of Value Sales for Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery and Vaginal Drug Delivery for the Years 2012, 2021 & 2027 |
IV. COMPETITION |
Total Companies Profiled: 43 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com